Literature DB >> 31790056

Relationship between office isolated systolic or diastolic hypertension and white-coat hypertension across the age spectrum: a home blood pressure study.

Audes D M Feitosa1,2,3, Marco A Mota-Gomes4,5, Weimar S Barroso6, Roberto D Miranda7, Eduardo C D Barbosa8, Rodrigo P Pedrosa2,3, Paula C Oliveira9, Camila L D M Feltosa2, Andréa A Brandão10, José L Lima-Filho1, Andrei C Sposito11, Antonio Coca12, Wilson Nadruz1,11.   

Abstract

OBJECTIVE: The current study investigated the prevalence of white-coat hypertension (WCH) and white-coat uncontrolled hypertension (WUCH) throughout the age spectrum among individuals with office isolated systolic hypertension (ISH), isolated diastolic hypertension (IDH) and systolic-diastolic hypertension (SDH) who were untreated or treated with antihypertensive medications, respectively.
METHODS: We cross-sectionally evaluated 8809 untreated (42% males, 52.1 ± 16.2 years) and 9136 treated (39% males, 59.7 ± 14.5 years) individuals from two independent Brazilian populations who underwent home blood pressure monitoring. Participants were also categorized as younger (<40 years), intermediate (≥40 and <60 years) and older (≥60 years) age.
RESULTS: Unadjusted and adjusted analyses showed that the frequency of WCH and WUCH was significantly greater (P < 0.05) in ISH and IDH than SDH at all age groups. Logistic regression analysis adjusted for sex, BMI and studied population showed that, compared with SDH, ISH had in average 4.1, 3.1 and 1.6-fold greater risk of WCH and 3.3, 3.6 and 2.0-fold greater risk of WUCH at younger, intermediate and older ages, whereas IDH had in average 2.3, 2.6 and 2.0-fold greater risk of WCH and 3.8, 3.2 and 3.8-fold greater risk of WUCH at younger, intermediate and older ages, respectively.
CONCLUSION: ISH and IDH were associated with higher prevalence of WCH and WUCH than SDH across all age spectrum. In addition, treated and untreated ISH individuals with age less than 60 years and treated IDH individuals of all ages had the highest risk of having WCH phenotypes.

Entities:  

Year:  2020        PMID: 31790056     DOI: 10.1097/HJH.0000000000002320

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Ambulatory blood pressure phenotypes and isolated elevation of office central or brachial blood pressure.

Authors:  Audes D M Feitosa; Annelise M G Paiva; Marco A Mota-Gomes; Andréa A Brandão; Andrei C Sposito; Wilson Nadruz
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-27       Impact factor: 3.738

2.  Discrepancies in the diagnosis of hypertension in adolescents according to available office and home high blood pressure criteria.

Authors:  Fabiana G A M Feitosa; Audes D M Feitosa; Marco A Mota-Gomes; Annelise M G Paiva; Weimar S Barroso; Roberto D Miranda; Eduardo C D Barbosa; Andréa A Brandão; Thiago S V Jardim; Paulo C B V Jardim; Arthur B M Feitosa; Maria V C Santos; José L Lima-Filho; Andrei C Sposito; Wilson Nadruz
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-09       Impact factor: 3.738

3.  Effect of age and isolated systolic or diastolic hypertension on target organ damage in non-dialysis patients with chronic kidney disease.

Authors:  Yu Hao; Xue Li; Ye Zhu; Jianting Ke; Tanqi Lou; Man Li; Cheng Wang
Journal:  Aging (Albany NY)       Date:  2021-02-22       Impact factor: 5.682

Review 4.  Hypertension and metabolic disorders, a glance from different phenotypes.

Authors:  Daniel Piskorz
Journal:  Am J Prev Cardiol       Date:  2020-07-03

5.  The impact of changing home blood pressure monitoring cutoff from 135/85 to 130/80 mmHg on hypertension phenotypes.

Authors:  Audes D M Feitosa; Marco A Mota-Gomes; Weimar S Barroso; Roberto D Miranda; Eduardo C D Barbosa; Andréa A Brandão; Fernando Nobre; Decio Mion; Celso Amodeo; José L Lima-Filho; Andrei C Sposito; Wilson Nadruz
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-06       Impact factor: 3.738

6.  Treated Hypertensive Patients Assessed by Home Blood Pressure Telemonitoring. TeleMRPA Study.

Authors:  Weimar Kunz Sebba Barroso; Audes Diógenes Magalhães Feitosa; Eduardo Costa Duarte Barbosa; Andréa Araujo Brandão; Roberto Dischinger Miranda; Priscila Valverde Oliveira Vitorino; Carlos Alberto Machado; Antônio Almeida Braga; Lúcio Paulo de Souza Ribeiro; Marco Antonio Mota-Gomes
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.